JPRN-C000000028已完成未知
(Olmesartan and Valsartan Anti-atherosclerosis Trial in Patients with Mild-Hypertension: Using Three-dimensional serial IVUS)Study - OVATION Study
The Department of Cardiology, Nagoya University Graduate School of Medicine0 个研究点目标入组 200 人开始时间: 2006年4月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(non-lesion related items) 1)Patients with acute coronary syndrome 2)Previous history of Q myocardial infarction within 4 weeks before the randomization 3)Low left ventricular(LV) function(LV ejection fraction < 45%) 4)Patients with renal failure(serum creatinine > 3.0mg) 5)Patients who are treated with angiotensin converting enzyme inhibitor or receptor blocker, or aldosterone receptor blocker at randomization (lesion related items) 1)chronic total coronary artery occlusion 2)lesions on bypass grafts 3)unsuccessful stent implantation (stenosis > 50% after PCI) 4)lesions with prior atheroablative procedures before stent implantation 5)lesions implanted with multiple stents 6)left main trunk lesions 7)lesions on small vessels(reference diameter < 2.0 mm) 8)calcified lesions, which preclude accurate quantification of IVUS imaging
研究者
相似试验
未知
不适用
Therapeutic efficacy of olmesartan, telmisartan and amlodipine to compare with histologic improvement and addciation about AGTR1 gene polymorphisms in subjects with nonalcoholic steatohepatitis (NASH); randomized open-labeled prospective study.on-alcoholic steatohepatitisJPRN-UMIN000001587Yokohama City University Hospital60
Unknown
2 期
The Effect of Rosuvastatin and Olmesartan on the Progression of Coronary Atherosclerotic DiseaseCoronary SyndromeNCT02516826Samsung Medical Center504
已完成
不适用
Effect of co-administration of Olmesartan and Azelnidipine on vascular endothelial function in patients with atherosclerosis-prone conditions.Patients with hypertension and atherosclerosis-prone conditions.JPRN-UMIN000004479Kitasato University School of Medicine, Cardioangiology20
已完成
4 期
Combination Therapy of Olmesartan and Azelnidipine or Valsartan and Amlodipine in Hypertensinve Patients StudyHypertensionJPRN-UMIN000004288Hiroshima University200
已完成
3 期
Olmesartan Medoxomil in AtherosclerosisEssential HypertensionAtherosclerotic Cardiovascular DiseaseNCT00185185Sankyo Pharma Gmbh165